141 related articles for article (PubMed ID: 21514146)
1. The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: a report from the Dana-Farber Cancer Institute ALL Consortium.
Vrooman LM; Neuberg DS; Stevenson KE; Asselin BL; Athale UH; Clavell L; Cole PD; Kelly KM; Larsen EC; Laverdière C; Michon B; Schorin M; Schwartz CL; Cohen HJ; Lipshultz SE; Silverman LB; Sallan SE
Eur J Cancer; 2011 Jun; 47(9):1373-9. PubMed ID: 21514146
[TBL] [Abstract][Full Text] [Related]
2. Impaired mitochondrial function is abrogated by dexrazoxane in doxorubicin-treated childhood acute lymphoblastic leukemia survivors.
Lipshultz SE; Anderson LM; Miller TL; Gerschenson M; Stevenson KE; Neuberg DS; Franco VI; LiButti DE; Silverman LB; Vrooman LM; Sallan SE;
Cancer; 2016 Mar; 122(6):946-53. PubMed ID: 26762648
[TBL] [Abstract][Full Text] [Related]
3. Dexrazoxane and Long-Term Heart Function in Survivors of Childhood Cancer.
Chow EJ; Aggarwal S; Doody DR; Aplenc R; Armenian SH; Baker KS; Bhatia S; Blythe N; Colan SD; Constine LS; Freyer DR; Kopp LM; Laverdière C; Leisenring WM; Sasaki N; Vrooman LM; Asselin BL; Schwartz CL; Lipshultz SE
J Clin Oncol; 2023 Apr; 41(12):2248-2257. PubMed ID: 36669148
[TBL] [Abstract][Full Text] [Related]
4. Caesarean delivery and risk of childhood leukaemia: a pooled analysis from the Childhood Leukemia International Consortium (CLIC).
Marcotte EL; Thomopoulos TP; Infante-Rivard C; Clavel J; Petridou ET; Schüz J; Ezzat S; Dockerty JD; Metayer C; Magnani C; Scheurer ME; Mueller BA; Mora AM; Wesseling C; Skalkidou A; Rashed WM; Francis SS; Ajrouche R; Erdmann F; Orsi L; Spector LG
Lancet Haematol; 2016 Apr; 3(4):e176-85. PubMed ID: 27063976
[TBL] [Abstract][Full Text] [Related]
5. Continuous Versus Bolus Infusion of Doxorubicin in Children With ALL: Long-term Cardiac Outcomes.
Lipshultz SE; Miller TL; Lipsitz SR; Neuberg DS; Dahlberg SE; Colan SD; Silverman LB; Henkel JM; Franco VI; Cushman LL; Asselin BL; Clavell LA; Athale U; Michon B; Laverdière C; Schorin MA; Larsen E; Usmani N; Sallan SE;
Pediatrics; 2012 Dec; 130(6):1003-11. PubMed ID: 23166343
[TBL] [Abstract][Full Text] [Related]
6. Age-, sex- and disease subtype-related foetal growth differentials in childhood acute myeloid leukaemia risk: A Childhood Leukemia International Consortium analysis.
Karalexi MA; Dessypris N; Ma X; Spector LG; Marcotte E; Clavel J; Pombo-de-Oliveira MS; Heck JE; Roman E; Mueller BA; Hansen J; Auvinen A; Lee PC; Schüz J; Magnani C; Mora AM; Dockerty JD; Scheurer ME; Wang R; Bonaventure A; Kane E; Doody DR; ; ; Erdmann F; Kang AY; Metayer C; Milne E; Petridou ET
Eur J Cancer; 2020 May; 130():1-11. PubMed ID: 32163883
[TBL] [Abstract][Full Text] [Related]
7. Dexrazoxane for cardioprotection in older adults with acute myeloid leukemia.
Vachhani P; Shin S; Baron J; Thompson JE; Wetzler M; Griffiths EA; Ontiveros EP; Spangenthal EJ; Wang ES
Leuk Res Rep; 2017; 7():36-39. PubMed ID: 28462084
[TBL] [Abstract][Full Text] [Related]
8. Childhood leukaemia and lymphoma: African experience supports a role for environmental factors in leukaemogenesis.
Williams CK; Foroni L; Luzzatto L; Saliu I; Levine A; Greaves MF
Ecancermedicalscience; 2014; 8():478. PubMed ID: 25435906
[TBL] [Abstract][Full Text] [Related]
9. Correction to: Cancer survivorship programs at the Dana-Farber Cancer Institute.
Partridge AH; Morgans A; Knelson LP; Recklitis C; Nekhlyudov L; Chi SN; Kenney LB; Diller L; Vrooman LM
J Cancer Surviv; 2024 Apr; ():. PubMed ID: 38607516
[No Abstract] [Full Text] [Related]
10. Pathological Report on Case of Myelogenous Leukæmia in an Infant, aged 18 months.
Whipham TR
Proc R Soc Med; 1910; 3(Sect Study Dis Child):152-4. PubMed ID: 19974724
[No Abstract] [Full Text] [Related]
11. Myelogenous Leukæmia in an Infant, aged 18 months.
Whipham TR
Proc R Soc Med; 1910; 3(Sect Study Dis Child):92-5. PubMed ID: 19974794
[No Abstract] [Full Text] [Related]
12. Case of Myelogenous Leukæmia in a Child of 13.
Wyard S
Proc R Soc Med; 1925; 18(Sect Study Dis Child):5-6. PubMed ID: 19984690
[No Abstract] [Full Text] [Related]
13. Administration of Dexrazoxane Improves Cardiac Indices in Children and Young Adults With Acute Myeloid Leukemia (AML) While Maintaining Survival Outcomes.
Schloemer NJ; Brickler M; Hoffmann R; Pan A; Simpson P; McFadden V; Block J; Tower RL; Burke MJ
J Pediatr Hematol Oncol; 2017 Jul; 39(5):e254-e258. PubMed ID: 28452856
[TBL] [Abstract][Full Text] [Related]
14. Cardioprotection and Safety of Dexrazoxane in Patients Treated for Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Advanced-Stage Lymphoblastic Non-Hodgkin Lymphoma: A Report of the Children's Oncology Group Randomized Trial Pediatric Oncology Group 9404.
Asselin BL; Devidas M; Chen L; Franco VI; Pullen J; Borowitz MJ; Hutchison RE; Ravindranath Y; Armenian SH; Camitta BM; Lipshultz SE
J Clin Oncol; 2016 Mar; 34(8):854-62. PubMed ID: 26700126
[TBL] [Abstract][Full Text] [Related]
15. Late Mortality After Dexrazoxane Treatment: A Report From the Children's Oncology Group.
Chow EJ; Asselin BL; Schwartz CL; Doody DR; Leisenring WM; Aggarwal S; Baker KS; Bhatia S; Constine LS; Freyer DR; Lipshultz SE; Armenian SH
J Clin Oncol; 2015 Aug; 33(24):2639-45. PubMed ID: 26014292
[TBL] [Abstract][Full Text] [Related]
16. Changes in cardiac biomarkers during doxorubicin treatment of pediatric patients with high-risk acute lymphoblastic leukemia: associations with long-term echocardiographic outcomes.
Lipshultz SE; Miller TL; Scully RE; Lipsitz SR; Rifai N; Silverman LB; Colan SD; Neuberg DS; Dahlberg SE; Henkel JM; Asselin BL; Athale UH; Clavell LA; Laverdière C; Michon B; Schorin MA; Sallan SE
J Clin Oncol; 2012 Apr; 30(10):1042-9. PubMed ID: 22370326
[TBL] [Abstract][Full Text] [Related]
17. Echocardiographic long-term follow-up of adult survivors of pediatric cancer treated with Dexrazoxane-Anthracyclines association.
Filomena D; Versacci P; Cimino S; Mattiucci C; Maestrini V; Cantisani D; Petronilli V; Agati L; Schiavetti A
Int J Cardiol; 2020 Jan; 299():271-275. PubMed ID: 31422879
[TBL] [Abstract][Full Text] [Related]
18. Dexrazoxane Significantly Reduces Anthracycline-induced Cardiotoxicity in Pediatric Solid Tumor Patients: A Systematic Review.
Liesse K; Harris J; Chan M; Schmidt ML; Chiu B
J Pediatr Hematol Oncol; 2018 Aug; 40(6):417-425. PubMed ID: 29432315
[TBL] [Abstract][Full Text] [Related]
19. Dexrazoxane use in pediatric patients with acute lymphoblastic or myeloid leukemia from 1999 and 2009: analysis of a national cohort of patients in the Pediatric Health Information Systems database.
Walker DM; Fisher BT; Seif AE; Huang YS; Torp K; Li Y; Aplenc R
Pediatr Blood Cancer; 2013 Apr; 60(4):616-20. PubMed ID: 22948886
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
